Communiqués IDEXX Laboratories, Inc. Sao Paulo

Actions

I1DX34

BRI1DXBDR001

Equipement, fournitures et distribution médicale

Marché Fermé - 21:37:02 25/09/2026 Varia. 5j. Varia. 1 janv.
538,10 BRL -7,05 % Graphique intraday de IDEXX Laboratories, Inc. +1,91 % -28,76 %

Communiqués

17/09 IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection BU
16/09 IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence BU
31/08 IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference BU
11/08 IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test BU
05/08 IDEXX Laboratories : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q) PU
04/08 IDEXX Laboratories : Earnings snapshot Q2 2026 PU
04/08 Idexx: Q2 Earnings Snapshot AQ
04/08 IDEXX Laboratories Announces Second Quarter Results BU
28/07 IDEXX Releases 2025 Corporate Responsibility Report, Highlighting Progress Against Its Goals BU
01/07 IDEXX Laboratories to Release 2026 Second Quarter Financial Results BU
26/05 IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection BU
19/05 IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles BU
14/05 IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day BU
06/05 IDEXX Laboratories : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) PU
05/05 IDEXX Laboratories : Earnings snapshot Q1 2026 PU
05/05 Idexx: Q1 Earnings Snapshot AQ
05/05 IDEXX Laboratories Announces First Quarter Results BU
05/05 Diagnostics, Vet Visits, Giving Pets a Voice: Jay Mazelsky & Jay Price AQ
08/04 IDEXX Laboratories to Release 2026 First Quarter Financial Results BU
01/04 IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma BU
02/03 IDEXX Laboratories : Raymond James Institutional Investors Conference Presentation PU
12/02 IDEXX Laboratories to Present at Two Institutional Investor Conferences BU
02/02 IDEXX Laboratories : Prepared remarks FY 2025 PU
02/02 Idexx: Q4 Earnings Snapshot AQ
02/02 IDEXX Laboratories : Earnings snapshot FY 2025 PU
Aucun résultat pour cette recherche
🔇